Prague, 03/07/2006 (Agence Europe) - The US is no longer el Dorado of medicines and Europe, with its latest review of pharmaceutical legislation and recent paediatric regulation, has managed to catch up on regulation. Of course there are still problems and the European Federation of Pharmaceutical Industries and Associations (EFPIA), on a number of occasions, at its general assembly on 28-30 June in Prague, underlined this fact. Problems are due to the segmentation of the market and...